au.\*:("HARDINGER, Karen L")
Results 1 to 12 of 12
Selection :
Influence of Pill Burden and Drug Cost on Renal Function After TransplantationHARDINGER, Karen L; HUTCHERSON, Timothy; PRESTON, David et al.Pharmacotherapy. 2012, Vol 32, Num 5, pp 427-432, issn 0277-0008, 6 p.Article
Adverse drug reaction driven immunosuppressive drug manipulations : a single-center comparison of enteric-coated mycophenolate sodium vs. mycophenolate mofetilHARDINGER, Karen L; HEBBAR, Sudarshan; BLOOMER, Terry et al.Clinical transplantation. 2008, Vol 22, Num 5, pp 555-561, issn 0902-0063, 7 p.Article
Rabbit Antithymocyte Globulin Is More Beneficial in Standard Kidney Than In Extended Donor RecipientsHARDINGER, Karen L; BRENNAN, Daniel C; SCHNITZLER, Mark A et al.Transplantation. 2009, Vol 87, Num 9, pp 1372-1376, issn 0041-1337, 5 p.Article
Sirolimus-induced leukocytoclastic vasculitisHARDINGER, Karen L; CORNELIUS, Lynn A; TRULOCK, Elbert P et al.Transplantation. 2002, Vol 74, Num 5, pp 739-740, issn 0041-1337Article
Renal allograft outcomes in African American versus Caucasian transplant recipients in the tacrolimus era. DiscussionHARDINGER, Karen L; STRATTA, Robert J; SCHULAK, James A et al.Surgery. 2001, Vol 130, Num 4, pp 738-747, issn 0039-6060Conference Paper
Thymoglobulin induction is safe and effective in live-donor renal transplantation : A single center experienceHARDINGER, Karen L; SCHNITZLER, Mark A; KOCH, Matthew J et al.Transplantation. 2006, Vol 81, Num 9, pp 1285-1289, issn 0041-1337, 5 p.Article
Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reductionBRENNAN, Daniel C; AGHA, Irfan; STORCH, Gregory A et al.American journal of transplantation (Print). 2005, Vol 5, Num 3, pp 582-594, issn 1600-6135, 13 p.Article
A Prospective, Randomized, Double-Blinded Comparison of Thymoglobulin Versus Atgam for Induction Immunosuppressive Therapy : 10-Year ResultsHARDINGER, Karen L; RHEE, Sunny; BUCHANAN, Paula et al.Transplantation. 2008, Vol 86, Num 7, pp 947-952, issn 0041-1337, 6 p.Article
Sirolimus conversion in liver transplant recipients with renal dysfunction: A prospective, randomized, single-center trialSHENOY, Surendra; HARDINGER, Karen L; CRIPPIN, Jeffrey et al.Transplantation. 2007, Vol 83, Num 10, pp 1389-1392, issn 0041-1337, 4 p.Article
A randomized, prospective, pharmacoeconomic trial of tacrolimus versus cyclosporine in combination with thymoglobulin in renal transplant recipientsHARDINGER, Karen L; BOHL, Daniel L; SCHNITZLER, Mark A et al.Transplantation. 2005, Vol 80, Num 1, pp 41-46, issn 0041-1337, 6 p.Article
Five-year follow up of Thymoglobulin versus atgam induction in adult renal transplantationHARDINGER, Karen L; SCHNITZLER, Mark A; MILLER, Brent et al.Transplantation. 2004, Vol 78, Num 1, pp 136-141, issn 0041-1337, 6 p.Article
Cytomegalovirus disease after prophylaxis with oral ganciclovir in renal transplantation: The importance of HLA-DR matchingSCHNITZLER, Mark A; LOWELL, Jeffrey A; HMIEL, S. Paul et al.Journal of the American Society of Nephrology. 2003, Vol 14, Num 3, pp 780-785, issn 1046-6673, 6 p.Article